HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Business (Health)

Set Alert for Business {Health}

Deals

Set Alert for Deals {Health}

Latest From Health & Deals

Pharma Dealmaker Saunders Includes Wellness Space In Acquisition Group’s Investment Targets

Brent Saunder’s Vesper Healthcare Acquisition Corp. wants to raise up to $460m in a forthcoming IPO to buy companies in health care and medical market niches including wellness.

Financing Dietary Supplements

Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment

Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.

Dietary Supplements Consumer

Takeda Exits Japan's OTC Market With Private-Equity Sale

Takeda is to offload its sizable Japanese OTC operation to private-equity firm Blackstone, which has committed to making the business the country's leading consumer health player.

Deals Japan
See All

Strategy

Set Alert for Business Strategy {Health}

Latest From Health & Business Strategies

On Appeal To Advertising Experts, P&G Gets Nod For ‘#1’ Claim With Brand Qualifier On Oral-B Picks

National Advertising Review Board says P&G’s #1” claim in a shield-shaped logo on Oral-B Precision Clean Interdental Picks package fronts “is adequately connected to the explanatory information," which states “from the makers of the #1 dentist recommended floss brand.”

Commercial OTC Devices

Fitbit Has OTC Electrocardiogram App To Rival Apple, Samsung With Clearance In US, EU

Fitbit will launch its new Fitbit Sense smartwatch with ECG app in Europe, US, Hong Kong and India in October. 

Approvals FDA

VGH Solutions Feels Pain In US Review For Basing OTC Device Ad Claims On Canada’s Approval

NAD advises VGH Solutions to pull pain relief claims and statements that am OTC device with FDA 510(k) clearance treats conditions including neuropathy. The firm offered studies and a Health Canada statement listing indications for the device to support claims not part of the US approved indication.

OTC Devices Enforcement
See All

Sales & Earnings

Set Alert for Sales & Earnings {Health}

Latest From Health & Sales & Earnings

Pharma Dealmaker Saunders Includes Wellness Space In Acquisition Group’s Investment Targets

Brent Saunder’s Vesper Healthcare Acquisition Corp. wants to raise up to $460m in a forthcoming IPO to buy companies in health care and medical market niches including wellness.

Financing Dietary Supplements

PharmaSGP's Chemical-Free OTCs A Hit With EU Consumers During COVID-19

Germany's PharmaSGP reported solid sales gains in the first half as European consumers snapped up its chemical-free OTCs and dietary supplement offering.

Sales & Earnings Europe

Stada Hints At Further Deals To Come As It Posts Big Sales Rise

Germany's Stada posts 22% jump in first half sales thanks to recent deals and reveals that more acquisitions may soon follow.

Sales & Earnings Business Strategies
See All

Litigation

Set Alert for Legal Issues {Health}

Latest From Health & Legal Issues

Vi-Jon Says Hand Sanitizer False Advertising Suit Glosses Over ‘Common Germs’ Disclosure

A class action complaint in California’s Southern District, challenging the hand sanitizer manufacturer’s 99.99% germ-kill claim, ignores the asterisk on products’ primary display panels that links to a disclosure on rear labels, “*Effective at eliminating 99.99% of many common harmful germs & bacteria," according to Vi-Jon's 27 August motion to dismiss.

United States Advertising, Marketing & Sales

Hand Sanitizer Class Actions Highlight Need For FDA Regulatory Update

A growing number of class action complainants allege that 99.99% germ-killing claims on hand sanitizers are false and misleading. The suits cite potentially dangerous microorganisms that, according to plaintiffs, are impervious to active ingredients used in the category, and argue that bacteria reductions do not necessarily translate to illness or infection prevention.

United States Legal Issues

Trump's Order For US Agencies To 'Buy American' Essential Medicines Has China Bracing For Impact

Many materials subject to order, APIs needed for OTC as well as Rx drugs, are supplied by companies outside the US, and China accounts for the bulk of them. The order didn't specify countries and products, leaving decisions to FDA.

Manufacturing Trade
See All
UsernamePublicRestriction

Register